Recruiting
Congenital leptin deficiency
RecruitingA Study of Mibavademab for Weight Loss in Children, Adolescents and Adults with Obesity Caused by LEP Gene Mutations
InvestigationalNo placebo
A Study of Mibavademab for Weight Loss in Children, Adolescents and Adults with Obesity Caused by LEP Gene Mutations
InvestigationalNo placebo
- Disease:Congenital leptin deficiency
- Substances:Mibavademab
Countries:
Germany
Germany- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Mibavademab
- Sponsor:Regeneron Pharmaceuticals Inc.

